134 related articles for article (PubMed ID: 20806167)
1. Efficacy of carboplatin plus vincristine in an optic pathway glioma.
Moschovi M; Alexiou GA; Papakonstantopoulou I; Gavra M; Sfakianos G; Prodromou N
Klin Padiatr; 2010 Nov; 222(6):395-6. PubMed ID: 20806167
[No Abstract] [Full Text] [Related]
2. Malignant transformation of an optic pathway glioma without prior radiation therapy.
Zoeller GK; Brathwaite CD; Sandberg DI
J Neurosurg Pediatr; 2010 May; 5(5):507-10. PubMed ID: 20433265
[TBL] [Abstract][Full Text] [Related]
3. Longitudinal measures of visual function, tumor volume, and prediction of visual outcomes after treatment of optic pathway gliomas.
Kelly JP; Leary S; Khanna P; Weiss AH
Ophthalmology; 2012 Jun; 119(6):1231-7. PubMed ID: 22364864
[TBL] [Abstract][Full Text] [Related]
4. Optic glioma warranting treatment in children.
Kaufman LM; Doroftei O
Eye (Lond); 2006 Oct; 20(10):1149-64. PubMed ID: 17019413
[TBL] [Abstract][Full Text] [Related]
5. Natural history and outcome of optic pathway gliomas in children.
Nicolin G; Parkin P; Mabbott D; Hargrave D; Bartels U; Tabori U; Rutka J; Buncic JR; Bouffet E
Pediatr Blood Cancer; 2009 Dec; 53(7):1231-7. PubMed ID: 19621457
[TBL] [Abstract][Full Text] [Related]
6. Low grade chiasmatic-hypothalamic glioma-carboplatin and vincristin chemotherapy effectively defers radiotherapy within a comprehensive treatment strategy -- report from the multicenter treatment study for children and adolescents with a low grade glioma -- HIT-LGG 1996 -- of the Society of Pediatric Oncology and Hematology (GPOH).
Gnekow AK; Kortmann RD; Pietsch T; Emser A
Klin Padiatr; 2004; 216(6):331-42. PubMed ID: 15565548
[TBL] [Abstract][Full Text] [Related]
7. Neurofibromatosis type 1 and optic pathway glioma. A long-term follow-up.
Lama G; Esposito Salsano M; Grassia C; Calabrese E; Grassia MG; Bismuto R; Melone MA; Russo S; Scuotto A
Minerva Pediatr; 2007 Feb; 59(1):13-21. PubMed ID: 17301720
[TBL] [Abstract][Full Text] [Related]
8. Optic-pathway glioma: natural history demonstrated by a new empirical score.
Schupper A; Kornreich L; Yaniv I; Cohen IJ; Shuper A
Pediatr Neurol; 2009 Jun; 40(6):432-6. PubMed ID: 19433276
[TBL] [Abstract][Full Text] [Related]
9. [Long-term outcome of gliomas of the visual pathway in type 1 neurofibromatosis].
Schröder S; Baumann-Schröder U; Hazim W; Haase W; Mautner VF
Klin Monbl Augenheilkd; 1999 Dec; 215(6):349-54. PubMed ID: 10637799
[TBL] [Abstract][Full Text] [Related]
10. Long-term response in high-grade optic glioma treated with medically induced hypothyroidism and carboplatin: a case report and review of the literature.
Ashur-Fabian O; Blumenthal DT; Bakon M; Nass D; Davis PJ; Hercbergs A
Anticancer Drugs; 2013 Mar; 24(3):315-23. PubMed ID: 23348245
[TBL] [Abstract][Full Text] [Related]
11. Long-term visual outcome after chemotherapy for optic pathway glioma in children: Site and age are strongly predictive.
Dodgshun AJ; Elder JE; Hansford JR; Sullivan MJ
Cancer; 2015 Dec; 121(23):4190-6. PubMed ID: 26280460
[TBL] [Abstract][Full Text] [Related]
12. Malignant optic nerve glioma (glioblastoma multiforme): A case report and literature review.
Hartel PH; Rosen C; Larzo C; Nestor S
W V Med J; 2006; 102(4):29-31. PubMed ID: 17111679
[TBL] [Abstract][Full Text] [Related]
13. Treatment results in patients with retinoblastoma and invasion to the cut end of the optic nerve.
Chantada GL; Guitter MR; Fandiño AC; Raslawski EC; de Davila MT; Vaiani E; Scopinaro MJ
Pediatr Blood Cancer; 2009 Feb; 52(2):218-22. PubMed ID: 18937327
[TBL] [Abstract][Full Text] [Related]
14. A novel mutation in the NF1 gene in two siblings with neurofibromatosis type 1 and bilateral optic pathway glioma.
Kebudi R; Tuncer S; Upadhyaya M; Peksayar G; Spurlock G; Yazici H
Pediatr Blood Cancer; 2008 Mar; 50(3):713-5. PubMed ID: 17514731
[TBL] [Abstract][Full Text] [Related]
15. Optic pathway hypothalamic gliomas in children under three years of age: the role of chemotherapy.
Silva MM; Goldman S; Keating G; Marymont MA; Kalapurakal J; Tomita T
Pediatr Neurosurg; 2000 Sep; 33(3):151-8. PubMed ID: 11096362
[TBL] [Abstract][Full Text] [Related]
16. Prechiasmatic transection of the optic nerve in optic nerve glioma: technical description and surgical outcome.
Borghei-Razavi H; Shibao S; Schick U
Neurosurg Rev; 2017 Jan; 40(1):135-141. PubMed ID: 27230830
[TBL] [Abstract][Full Text] [Related]
17. Follow-up of optic pathway gliomas in children with neurofibromatosis type 1.
Kuenzle C; Weissert M; Roulet E; Bode H; Schefer S; Huisman T; Landau K; Boltshauser E
Neuropediatrics; 1994 Dec; 25(6):295-300. PubMed ID: 7770126
[TBL] [Abstract][Full Text] [Related]
18. Optic radiation involvement in optic pathway gliomas in neurofibromatosis.
Liu GT; Brodsky MC; Phillips PC; Belasco J; Janss A; Golden JC; Bilaniuk LL; Burson GT; Duhaime AC; Sutton LN
Am J Ophthalmol; 2004 Mar; 137(3):407-14. PubMed ID: 15013861
[TBL] [Abstract][Full Text] [Related]
19. Remarkable regression of optic glioma in an infant. Case illustration.
Yoshikawa G; Nagata K; Kawamoto S; Tsutsumi K
J Neurosurg; 2003 May; 98(5):1134. PubMed ID: 12744380
[No Abstract] [Full Text] [Related]
20. Visual outcome following chemotherapy for progressive optic pathway gliomas.
Shofty B; Ben-Sira L; Freedman S; Yalon M; Dvir R; Weintraub M; Toledano H; Constantini S; Kesler A
Pediatr Blood Cancer; 2011 Sep; 57(3):481-5. PubMed ID: 21241008
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
